title: BIOMEDICINE. Targeting copper to treat breast cancer.
authors.forename: Ken
authors.initials: K
authors.lastname: Garber
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D002614:Chelating Agents / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D003300:Copper / Q000378:metabolism*; D005260:Female; D006801:Humans; D008327:Mammography; D058990:Molecular Targeted Therapy; D008982:Molybdenum / Q000627:therapeutic use*; D064726:Triple Negative Breast Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D002614:Chelating Agents; D003300:Copper; D008982:Molybdenum; C020809:tetrathiomolybdate